Anthelmintics are drugs that work on helminths as either vermicides (by killing) or vermifuges (by expelling).
This report aims to provide a comprehensive presentation of the global market for Anthelmintic Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Anthelmintic Drugs. This report contains market size and forecasts of Anthelmintic Drugs in global, including the following market information:
Global Anthelmintic Drugs Market Revenue, 2018-2023, 2024-2030, ($ millions)
Global Anthelmintic Drugs Market Sales, 2018-2023, 2024-2030, (K Units)
Global top five Anthelmintic Drugs companies in 2022 (%)
The global Anthelmintic Drugs market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is Forecast to Reach $ Million.
Oral Drugs Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Anthelmintic Drugs include Novartis, Pfizer, Bayer, Cipla, Sun Pharmaceutical Industries, Mankind Pharma, Johnson & Johnson and Merck, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
We surveyed the Anthelmintic Drugs manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Anthelmintic Drugs Market, by Type, 2018-2023, 2024-2030 ($ Millions) & (K Units)
Global Anthelmintic Drugs Market Segment Percentages, by Type, 2022 (%)
Oral Drugs
Injectables
Global Anthelmintic Drugs Market, by Application, 2018-2023, 2024-2030 ($ Millions) & (K Units)
Global Anthelmintic Drugs Market Segment Percentages, by Application, 2022 (%)
For Human
For Animal
Global Anthelmintic Drugs Market, By Region and Country, 2018-2023, 2024-2030 ($ Millions) & (K Units)
Global Anthelmintic Drugs Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Anthelmintic Drugs revenues in global market, 2018-2023 (Estimated), ($ millions)
Key companies Anthelmintic Drugs revenues share in global market, 2022 (%)
Key companies Anthelmintic Drugs sales in global market, 2018-2023 (Estimated), (K Units)
Key companies Anthelmintic Drugs sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Novartis
Pfizer
Bayer
Cipla
Sun Pharmaceutical Industries
Mankind Pharma
Johnson & Johnson
Merck
Outline of Major Chapters:
Chapter 1: Introduces the definition of Anthelmintic Drugs, market overview.
Chapter 2: Global Anthelmintic Drugs market size in revenue and volume.
Chapter 3: Detailed analysis of Anthelmintic Drugs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Anthelmintic Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Anthelmintic Drugs capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Anthelmintic Drugs Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Anthelmintic Drugs Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Anthelmintic Drugs Overall Market Size
2.1 Global Anthelmintic Drugs Market Size: 2022 VS 2030
2.2 Global Anthelmintic Drugs Revenue, Prospects & Forecasts: 2018-2030
2.3 Global Anthelmintic Drugs Sales: 2018-2030
3 Company Landscape
3.1 Top Anthelmintic Drugs Players in Global Market
3.2 Top Global Anthelmintic Drugs Companies Ranked by Revenue
3.3 Global Anthelmintic Drugs Revenue by Companies
3.4 Global Anthelmintic Drugs Sales by Companies
3.5 Global Anthelmintic Drugs Price by Manufacturer (2018-2023)
3.6 Top 3 and Top 5 Anthelmintic Drugs Companies in Global Market, by Revenue in 2022
3.7 Global Manufacturers Anthelmintic Drugs Product Type
3.8 Tier 1, Tier 2 and Tier 3 Anthelmintic Drugs Players in Global Market
3.8.1 List of Global Tier 1 Anthelmintic Drugs Companies
3.8.2 List of Global Tier 2 and Tier 3 Anthelmintic Drugs Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type - Global Anthelmintic Drugs Market Size Markets, 2022 & 2030
4.1.2 Oral Drugs
4.1.3 Injectables
4.2 By Type - Global Anthelmintic Drugs Revenue & Forecasts
4.2.1 By Type - Global Anthelmintic Drugs Revenue, 2018-2023
4.2.2 By Type - Global Anthelmintic Drugs Revenue, 2024-2030
4.2.3 By Type - Global Anthelmintic Drugs Revenue Market Share, 2018-2030
4.3 By Type - Global Anthelmintic Drugs Sales & Forecasts
4.3.1 By Type - Global Anthelmintic Drugs Sales, 2018-2023
4.3.2 By Type - Global Anthelmintic Drugs Sales, 2024-2030
4.3.3 By Type - Global Anthelmintic Drugs Sales Market Share, 2018-2030
4.4 By Type - Global Anthelmintic Drugs Price (Manufacturers Selling Prices), 2018-2030
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Anthelmintic Drugs Market Size, 2022 & 2030
5.1.2 For Human
5.1.3 For Animal
5.2 By Application - Global Anthelmintic Drugs Revenue & Forecasts
5.2.1 By Application - Global Anthelmintic Drugs Revenue, 2018-2023
5.2.2 By Application - Global Anthelmintic Drugs Revenue, 2024-2030
5.2.3 By Application - Global Anthelmintic Drugs Revenue Market Share, 2018-2030
5.3 By Application - Global Anthelmintic Drugs Sales & Forecasts
5.3.1 By Application - Global Anthelmintic Drugs Sales, 2018-2023
5.3.2 By Application - Global Anthelmintic Drugs Sales, 2024-2030
5.3.3 By Application - Global Anthelmintic Drugs Sales Market Share, 2018-2030
5.4 By Application - Global Anthelmintic Drugs Price (Manufacturers Selling Prices), 2018-2030
6 Sights by Region
6.1 By Region - Global Anthelmintic Drugs Market Size, 2022 & 2030
6.2 By Region - Global Anthelmintic Drugs Revenue & Forecasts
6.2.1 By Region - Global Anthelmintic Drugs Revenue, 2018-2023
6.2.2 By Region - Global Anthelmintic Drugs Revenue, 2024-2030
6.2.3 By Region - Global Anthelmintic Drugs Revenue Market Share, 2018-2030
6.3 By Region - Global Anthelmintic Drugs Sales & Forecasts
6.3.1 By Region - Global Anthelmintic Drugs Sales, 2018-2023
6.3.2 By Region - Global Anthelmintic Drugs Sales, 2024-2030
6.3.3 By Region - Global Anthelmintic Drugs Sales Market Share, 2018-2030
6.4 North America
6.4.1 By Country - North America Anthelmintic Drugs Revenue, 2018-2030
6.4.2 By Country - North America Anthelmintic Drugs Sales, 2018-2030
6.4.3 US Anthelmintic Drugs Market Size, 2018-2030
6.4.4 Canada Anthelmintic Drugs Market Size, 2018-2030
6.4.5 Mexico Anthelmintic Drugs Market Size, 2018-2030
6.5 Europe
6.5.1 By Country - Europe Anthelmintic Drugs Revenue, 2018-2030
6.5.2 By Country - Europe Anthelmintic Drugs Sales, 2018-2030
6.5.3 Germany Anthelmintic Drugs Market Size, 2018-2030
6.5.4 France Anthelmintic Drugs Market Size, 2018-2030
6.5.5 U.K. Anthelmintic Drugs Market Size, 2018-2030
6.5.6 Italy Anthelmintic Drugs Market Size, 2018-2030
6.5.7 Russia Anthelmintic Drugs Market Size, 2018-2030
6.5.8 Nordic Countries Anthelmintic Drugs Market Size, 2018-2030
6.5.9 Benelux Anthelmintic Drugs Market Size, 2018-2030
6.6 Asia
6.6.1 By Region - Asia Anthelmintic Drugs Revenue, 2018-2030
6.6.2 By Region - Asia Anthelmintic Drugs Sales, 2018-2030
6.6.3 China Anthelmintic Drugs Market Size, 2018-2030
6.6.4 Japan Anthelmintic Drugs Market Size, 2018-2030
6.6.5 South Korea Anthelmintic Drugs Market Size, 2018-2030
6.6.6 Southeast Asia Anthelmintic Drugs Market Size, 2018-2030
6.6.7 India Anthelmintic Drugs Market Size, 2018-2030
6.7 South America
6.7.1 By Country - South America Anthelmintic Drugs Revenue, 2018-2030
6.7.2 By Country - South America Anthelmintic Drugs Sales, 2018-2030
6.7.3 Brazil Anthelmintic Drugs Market Size, 2018-2030
6.7.4 Argentina Anthelmintic Drugs Market Size, 2018-2030
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Anthelmintic Drugs Revenue, 2018-2030
6.8.2 By Country - Middle East & Africa Anthelmintic Drugs Sales, 2018-2030
6.8.3 Turkey Anthelmintic Drugs Market Size, 2018-2030
6.8.4 Israel Anthelmintic Drugs Market Size, 2018-2030
6.8.5 Saudi Arabia Anthelmintic Drugs Market Size, 2018-2030
6.8.6 UAE Anthelmintic Drugs Market Size, 2018-2030
7 Manufacturers & Brands Profiles
7.1 Novartis
7.1.1 Novartis Company Summary
7.1.2 Novartis Business Overview
7.1.3 Novartis Anthelmintic Drugs Major Product Offerings
7.1.4 Novartis Anthelmintic Drugs Sales and Revenue in Global (2018-2023)
7.1.5 Novartis Key News & Latest Developments
7.2 Pfizer
7.2.1 Pfizer Company Summary
7.2.2 Pfizer Business Overview
7.2.3 Pfizer Anthelmintic Drugs Major Product Offerings
7.2.4 Pfizer Anthelmintic Drugs Sales and Revenue in Global (2018-2023)
7.2.5 Pfizer Key News & Latest Developments
7.3 Bayer
7.3.1 Bayer Company Summary
7.3.2 Bayer Business Overview
7.3.3 Bayer Anthelmintic Drugs Major Product Offerings
7.3.4 Bayer Anthelmintic Drugs Sales and Revenue in Global (2018-2023)
7.3.5 Bayer Key News & Latest Developments
7.4 Cipla
7.4.1 Cipla Company Summary
7.4.2 Cipla Business Overview
7.4.3 Cipla Anthelmintic Drugs Major Product Offerings
7.4.4 Cipla Anthelmintic Drugs Sales and Revenue in Global (2018-2023)
7.4.5 Cipla Key News & Latest Developments
7.5 Sun Pharmaceutical Industries
7.5.1 Sun Pharmaceutical Industries Company Summary
7.5.2 Sun Pharmaceutical Industries Business Overview
7.5.3 Sun Pharmaceutical Industries Anthelmintic Drugs Major Product Offerings
7.5.4 Sun Pharmaceutical Industries Anthelmintic Drugs Sales and Revenue in Global (2018-2023)
7.5.5 Sun Pharmaceutical Industries Key News & Latest Developments
7.6 Mankind Pharma
7.6.1 Mankind Pharma Company Summary
7.6.2 Mankind Pharma Business Overview
7.6.3 Mankind Pharma Anthelmintic Drugs Major Product Offerings
7.6.4 Mankind Pharma Anthelmintic Drugs Sales and Revenue in Global (2018-2023)
7.6.5 Mankind Pharma Key News & Latest Developments
7.7 Johnson & Johnson
7.7.1 Johnson & Johnson Company Summary
7.7.2 Johnson & Johnson Business Overview
7.7.3 Johnson & Johnson Anthelmintic Drugs Major Product Offerings
7.7.4 Johnson & Johnson Anthelmintic Drugs Sales and Revenue in Global (2018-2023)
7.7.5 Johnson & Johnson Key News & Latest Developments
7.8 Merck
7.8.1 Merck Company Summary
7.8.2 Merck Business Overview
7.8.3 Merck Anthelmintic Drugs Major Product Offerings
7.8.4 Merck Anthelmintic Drugs Sales and Revenue in Global (2018-2023)
7.8.5 Merck Key News & Latest Developments
8 Global Anthelmintic Drugs Production Capacity, Analysis
8.1 Global Anthelmintic Drugs Production Capacity, 2018-2030
8.2 Anthelmintic Drugs Production Capacity of Key Manufacturers in Global Market
8.3 Global Anthelmintic Drugs Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Anthelmintic Drugs Supply Chain Analysis
10.1 Anthelmintic Drugs Industry Value Chain
10.2 Anthelmintic Drugs Upstream Market
10.3 Anthelmintic Drugs Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Anthelmintic Drugs Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Key Players of Anthelmintic Drugs in Global Market
Table 2. Top Anthelmintic Drugs Players in Global Market, Ranking by Revenue (2022)
Table 3. Global Anthelmintic Drugs Revenue by Companies, (US$, Mn), 2018-2023
Table 4. Global Anthelmintic Drugs Revenue Share by Companies, 2018-2023
Table 5. Global Anthelmintic Drugs Sales by Companies, (K Units), 2018-2023
Table 6. Global Anthelmintic Drugs Sales Share by Companies, 2018-2023
Table 7. Key Manufacturers Anthelmintic Drugs Price (2018-2023) & (USD/Unit)
Table 8. Global Manufacturers Anthelmintic Drugs Product Type
Table 9. List of Global Tier 1 Anthelmintic Drugs Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Anthelmintic Drugs Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global Anthelmintic Drugs Revenue, (US$, Mn), 2022 & 2030
Table 12. By Type - Global Anthelmintic Drugs Revenue (US$, Mn), 2018-2023
Table 13. By Type - Global Anthelmintic Drugs Revenue (US$, Mn), 2024-2030
Table 14. By Type - Global Anthelmintic Drugs Sales (K Units), 2018-2023
Table 15. By Type - Global Anthelmintic Drugs Sales (K Units), 2024-2030
Table 16. By Application ? Global Anthelmintic Drugs Revenue, (US$, Mn), 2022 & 2030
Table 17. By Application - Global Anthelmintic Drugs Revenue (US$, Mn), 2018-2023
Table 18. By Application - Global Anthelmintic Drugs Revenue (US$, Mn), 2024-2030
Table 19. By Application - Global Anthelmintic Drugs Sales (K Units), 2018-2023
Table 20. By Application - Global Anthelmintic Drugs Sales (K Units), 2024-2030
Table 21. By Region ? Global Anthelmintic Drugs Revenue, (US$, Mn), 2022 VS 2030
Table 22. By Region - Global Anthelmintic Drugs Revenue (US$, Mn), 2018-2023
Table 23. By Region - Global Anthelmintic Drugs Revenue (US$, Mn), 2024-2030
Table 24. By Region - Global Anthelmintic Drugs Sales (K Units), 2018-2023
Table 25. By Region - Global Anthelmintic Drugs Sales (K Units), 2024-2030
Table 26. By Country - North America Anthelmintic Drugs Revenue, (US$, Mn), 2018-2023
Table 27. By Country - North America Anthelmintic Drugs Revenue, (US$, Mn), 2024-2030
Table 28. By Country - North America Anthelmintic Drugs Sales, (K Units), 2018-2023
Table 29. By Country - North America Anthelmintic Drugs Sales, (K Units), 2024-2030
Table 30. By Country - Europe Anthelmintic Drugs Revenue, (US$, Mn), 2018-2023
Table 31. By Country - Europe Anthelmintic Drugs Revenue, (US$, Mn), 2024-2030
Table 32. By Country - Europe Anthelmintic Drugs Sales, (K Units), 2018-2023
Table 33. By Country - Europe Anthelmintic Drugs Sales, (K Units), 2024-2030
Table 34. By Region - Asia Anthelmintic Drugs Revenue, (US$, Mn), 2018-2023
Table 35. By Region - Asia Anthelmintic Drugs Revenue, (US$, Mn), 2024-2030
Table 36. By Region - Asia Anthelmintic Drugs Sales, (K Units), 2018-2023
Table 37. By Region - Asia Anthelmintic Drugs Sales, (K Units), 2024-2030
Table 38. By Country - South America Anthelmintic Drugs Revenue, (US$, Mn), 2018-2023
Table 39. By Country - South America Anthelmintic Drugs Revenue, (US$, Mn), 2024-2030
Table 40. By Country - South America Anthelmintic Drugs Sales, (K Units), 2018-2023
Table 41. By Country - South America Anthelmintic Drugs Sales, (K Units), 2024-2030
Table 42. By Country - Middle East & Africa Anthelmintic Drugs Revenue, (US$, Mn), 2018-2023
Table 43. By Country - Middle East & Africa Anthelmintic Drugs Revenue, (US$, Mn), 2024-2030
Table 44. By Country - Middle East & Africa Anthelmintic Drugs Sales, (K Units), 2018-2023
Table 45. By Country - Middle East & Africa Anthelmintic Drugs Sales, (K Units), 2024-2030
Table 46. Novartis Company Summary
Table 47. Novartis Anthelmintic Drugs Product Offerings
Table 48. Novartis Anthelmintic Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 49. Novartis Key News & Latest Developments
Table 50. Pfizer Company Summary
Table 51. Pfizer Anthelmintic Drugs Product Offerings
Table 52. Pfizer Anthelmintic Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 53. Pfizer Key News & Latest Developments
Table 54. Bayer Company Summary
Table 55. Bayer Anthelmintic Drugs Product Offerings
Table 56. Bayer Anthelmintic Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 57. Bayer Key News & Latest Developments
Table 58. Cipla Company Summary
Table 59. Cipla Anthelmintic Drugs Product Offerings
Table 60. Cipla Anthelmintic Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 61. Cipla Key News & Latest Developments
Table 62. Sun Pharmaceutical Industries Company Summary
Table 63. Sun Pharmaceutical Industries Anthelmintic Drugs Product Offerings
Table 64. Sun Pharmaceutical Industries Anthelmintic Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 65. Sun Pharmaceutical Industries Key News & Latest Developments
Table 66. Mankind Pharma Company Summary
Table 67. Mankind Pharma Anthelmintic Drugs Product Offerings
Table 68. Mankind Pharma Anthelmintic Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 69. Mankind Pharma Key News & Latest Developments
Table 70. Johnson & Johnson Company Summary
Table 71. Johnson & Johnson Anthelmintic Drugs Product Offerings
Table 72. Johnson & Johnson Anthelmintic Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 73. Johnson & Johnson Key News & Latest Developments
Table 74. Merck Company Summary
Table 75. Merck Anthelmintic Drugs Product Offerings
Table 76. Merck Anthelmintic Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 77. Merck Key News & Latest Developments
Table 78. Anthelmintic Drugs Production Capacity (K Units) of Key Manufacturers in Global Market, 2021-2023 (K Units)
Table 79. Global Anthelmintic Drugs Capacity Market Share of Key Manufacturers, 2021-2023
Table 80. Global Anthelmintic Drugs Production by Region, 2018-2023 (K Units)
Table 81. Global Anthelmintic Drugs Production by Region, 2024-2030 (K Units)
Table 82. Anthelmintic Drugs Market Opportunities & Trends in Global Market
Table 83. Anthelmintic Drugs Market Drivers in Global Market
Table 84. Anthelmintic Drugs Market Restraints in Global Market
Table 85. Anthelmintic Drugs Raw Materials
Table 86. Anthelmintic Drugs Raw Materials Suppliers in Global Market
Table 87. Typical Anthelmintic Drugs Downstream
Table 88. Anthelmintic Drugs Downstream Clients in Global Market
Table 89. Anthelmintic Drugs Distributors and Sales Agents in Global Market
List of Figures
Figure 1. Anthelmintic Drugs Segment by Type in 2022
Figure 2. Anthelmintic Drugs Segment by Application in 2022
Figure 3. Global Anthelmintic Drugs Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Anthelmintic Drugs Market Size: 2022 VS 2030 (US$, Mn)
Figure 6. Global Anthelmintic Drugs Revenue, 2018-2030 (US$, Mn)
Figure 7. Anthelmintic Drugs Sales in Global Market: 2018-2030 (K Units)
Figure 8. The Top 3 and 5 Players Market Share by Anthelmintic Drugs Revenue in 2022
Figure 9. By Type - Global Anthelmintic Drugs Revenue, (US$, Mn), 2022 & 2030
Figure 10. By Type - Global Anthelmintic Drugs Revenue Market Share, 2018-2030
Figure 11. By Type - Global Anthelmintic Drugs Sales Market Share, 2018-2030
Figure 12. By Type - Global Anthelmintic Drugs Price (USD/Unit), 2018-2030
Figure 13. By Application - Global Anthelmintic Drugs Revenue, (US$, Mn), 2022 & 2030
Figure 14. By Application - Global Anthelmintic Drugs Revenue Market Share, 2018-2030
Figure 15. By Application - Global Anthelmintic Drugs Sales Market Share, 2018-2030
Figure 16. By Application - Global Anthelmintic Drugs Price (USD/Unit), 2018-2030
Figure 17. By Region - Global Anthelmintic Drugs Revenue, (US$, Mn), 2022 & 2030
Figure 18. By Region - Global Anthelmintic Drugs Revenue Market Share, 2018 VS 2022 VS 2030
Figure 19. By Region - Global Anthelmintic Drugs Revenue Market Share, 2018-2030
Figure 20. By Region - Global Anthelmintic Drugs Sales Market Share, 2018-2030
Figure 21. By Country - North America Anthelmintic Drugs Revenue Market Share, 2018-2030
Figure 22. By Country - North America Anthelmintic Drugs Sales Market Share, 2018-2030
Figure 23. US Anthelmintic Drugs Revenue, (US$, Mn), 2018-2030
Figure 24. Canada Anthelmintic Drugs Revenue, (US$, Mn), 2018-2030
Figure 25. Mexico Anthelmintic Drugs Revenue, (US$, Mn), 2018-2030
Figure 26. By Country - Europe Anthelmintic Drugs Revenue Market Share, 2018-2030
Figure 27. By Country - Europe Anthelmintic Drugs Sales Market Share, 2018-2030
Figure 28. Germany Anthelmintic Drugs Revenue, (US$, Mn), 2018-2030
Figure 29. France Anthelmintic Drugs Revenue, (US$, Mn), 2018-2030
Figure 30. U.K. Anthelmintic Drugs Revenue, (US$, Mn), 2018-2030
Figure 31. Italy Anthelmintic Drugs Revenue, (US$, Mn), 2018-2030
Figure 32. Russia Anthelmintic Drugs Revenue, (US$, Mn), 2018-2030
Figure 33. Nordic Countries Anthelmintic Drugs Revenue, (US$, Mn), 2018-2030
Figure 34. Benelux Anthelmintic Drugs Revenue, (US$, Mn), 2018-2030
Figure 35. By Region - Asia Anthelmintic Drugs Revenue Market Share, 2018-2030
Figure 36. By Region - Asia Anthelmintic Drugs Sales Market Share, 2018-2030
Figure 37. China Anthelmintic Drugs Revenue, (US$, Mn), 2018-2030
Figure 38. Japan Anthelmintic Drugs Revenue, (US$, Mn), 2018-2030
Figure 39. South Korea Anthelmintic Drugs Revenue, (US$, Mn), 2018-2030
Figure 40. Southeast Asia Anthelmintic Drugs Revenue, (US$, Mn), 2018-2030
Figure 41. India Anthelmintic Drugs Revenue, (US$, Mn), 2018-2030
Figure 42. By Country - South America Anthelmintic Drugs Revenue Market Share, 2018-2030
Figure 43. By Country - South America Anthelmintic Drugs Sales Market Share, 2018-2030
Figure 44. Brazil Anthelmintic Drugs Revenue, (US$, Mn), 2018-2030
Figure 45. Argentina Anthelmintic Drugs Revenue, (US$, Mn), 2018-2030
Figure 46. By Country - Middle East & Africa Anthelmintic Drugs Revenue Market Share, 2018-2030
Figure 47. By Country - Middle East & Africa Anthelmintic Drugs Sales Market Share, 2018-2030
Figure 48. Turkey Anthelmintic Drugs Revenue, (US$, Mn), 2018-2030
Figure 49. Israel Anthelmintic Drugs Revenue, (US$, Mn), 2018-2030
Figure 50. Saudi Arabia Anthelmintic Drugs Revenue, (US$, Mn), 2018-2030
Figure 51. UAE Anthelmintic Drugs Revenue, (US$, Mn), 2018-2030
Figure 52. Global Anthelmintic Drugs Production Capacity (K Units), 2018-2030
Figure 53. The Percentage of Production Anthelmintic Drugs by Region, 2022 VS 2030
Figure 54. Anthelmintic Drugs Industry Value Chain
Figure 55. Marketing Channels
